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The function of marrow adipocytes and their origin has not been defined although 
considerable research has centered on their presence in certain conditions, such as 
osteoporosis. Less work has focused on the qualitative aspects of marrow fat. Bone 
marrow serum is composed of multiple nutrients that almost certainly relate to functional 
aspects of the niche. Previous studies using non-invasive techniques have shown that 
osteoporotic individuals have more marrow fat and that the ratio of saturated: unsatu-
rated fatty acid is high. We recently reported that bone marrow sera from osteoporotic 
patients with fracture showed a switch toward decreased content of total saturated 
versus unsaturated fatty acids, compared to patients without fracture highlighting a 
dynamic relationship between the composition of fatty acids in the bone microenviron-
ment and the metabolic requirements of cells. The relative distribution of fatty acids 
differed considerably from that in the serum providing further evidence that energy 
utilization is high and that marrow adipocytes may contribute to this pool. Whether these 
lipids can affect osteoblast function in a positive or negative manner is still not certain but 
will require further investigation.
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tHe Bone MarroW MiCroenViroMent
In adults, the rigid bone structure of the cortex encloses a dynamic and flexible cell organization 
sustaining continuous bone and bone marrow stroma remodeling, as well as blood formation. These 
processes rest on preserving specific adult stem cells (SCs) that are characterized by their capacity 
for self-renewal and multilineage differentiation. These unique properties of SCs are not only cell-
autonomous in vivo, but also controlled by their surrounding microenvironment, which is currently 
called the SC niche. The original Schofield’s proposition for hematopoietic stem cells (HSCs) in the 
bone marrow emphasized the input from other marrow cells types to maintain SCs behavior and 
prevent maturation (1). Such cell- depending interactions provide a specialized microenvironment 
(“niche”) that allows cell lodging while maintaining self-renewal of SCs; loss of such an association 
would lead to cell differentiation. At present, the niche concept has been assumed to explain the 
behavior of SCs in several tissue types while evolving to take account of specific cell types, anatomical 
sites, soluble molecules, signaling cascades and gradients, as well as physical factors, such as weight 
bearing, shear stress, oxygen tension, and temperature (2–5). Among the most studied somatic SCs 
in mammals are the HSC and mesenchymal stromal/stem cells (MSCs) that integrate a unique niche 
in the bone marrow made of heterotypic SC pairs (6). Therefore, the bone marrow niche concept 
comprises a complex microenvironment, providing spatial and temporal coordinated signals to 
support SC function; balanced inputs from the niche can sustain homeostatic SC self-renewal and 
differentiation, but under pathological conditions they could constrain SCs functioning.
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MesenCHyMaL steM CeLLs or 
MarroW stroMaL CeLLs
In the bone marrow, MSCs mainly localize lining blood vessels, 
in particular on the sinusoids, the characteristic vessels of bone 
marrow microcirculation (7, 8), often in close association with 
HSCs (6, 9, 10). Then, the sinusoidal wall brings together both 
HSCs and MSCs, framing and sustaining a mutual niche (6, 11). 
Such perivascular localization has also been demonstrated for 
MSCs in several tissues through the body, which support the 
proposition that MSCs are fundamental to the healing of many 
tissues. MSCs in the bone marrow are ontogenically distinct 
populations taking over various biological functions, such as 
niches for HSCs (6, 12, 13), progenitor cells for bone formation 
during bone remodeling or repair (14), for cartilage and adipo-
cyte formation, and vascular support (15–17).
Ex vivo, hMSCs are relatively easy to obtain from a small 
bone marrow aspirate and they can simply be isolated from 
other marrow nucleated cells by their adherence to plastic dishes. 
Subsequently, these cells can be expanded under in vitro condi-
tions in which they display varying proliferation and differentia-
tion potential; however, as cells are expanded consecutively under 
standard conditions, they lose some of these capacities. Clonal 
analysis demonstrated that MSCs obtained from the bone mar-
row are a heterogeneous mixture of cells that differ in their stage 
of lineage commitment and extent of differentiation (18–21). 
Therefore, MSCs populations in the bone marrow or those that 
are isolated and maintained in culture are not homogeneous, but 
rather assemble progenitor cells with diverse biological proper-
ties, such that not all MSCs are alike.
In theory, the lineage fate of MSCs appears to be determined 
during cell “commitment,” at very early stages of cell differentia-
tion. During this almost unknown period, both intrinsic (genetic) 
and environmental (local and/or systemic) conditions interplay to 
outline the cell’s fate toward one of the possible lineages. Factors, 
such as age (22), culture condition (23), microenvironment (24), 
mechanical strain (25), and some pathologies (26, 27), appear to 
affect the intrinsic activity of MSCs.
Multilineage differentiation capacity has been related to 
wide range gene expression at intermediary levels, which along 
cell commitment and differentiation shifts to a selective mode 
of restricted genes expressed at high level (21, 28–30). Several 
fundamental signaling pathways participate in regulating the 
lineage commitment of MSCs, including transforming growth 
factor-beta (TGFβ)/bone morphogenic protein (BMP) signaling, 
wingless type MMTV integration site (Wnt) signaling, Hedgehogs 
(Hh), Notch, and fibroblast growth factors (FGFs) (31, 32).
reLationsHip BetWeen tHe osteo/
adipoGeniC proCesses tHe oBesity 
tHeory oF osteoporosis
The formation, maintenance, and repair of bone tissue depend 
on fine-tuned interlinks in the activities of cells derived from 
the two SC types housed in the bone marrow interstice, above 
described. HSCs along the myeloid differentiation lineage 
generate osteoclasts (33), whereas osteoblasts derive from 
MSCs, which are also progenitor cells for adipocytes (34). Bone 
diseases, such as osteopetrosis, osteopenia, and osteoporosis, 
show imbalance between bone formation and resorption (33).
Since MSCs can generate several cell types, the control of 
lineage commitment of MSCs appears critical. Alteration in such 
control has been observed in some bone diseases resulting in 
abnormal bone remodeling, which show divergent commitment 
of MSCs to adipocytes and osteoblasts. For instance, increased 
marrow fat content has been demonstrated in osteoporosis 
patients, the most common bone remodeling disorder (35, 36). 
Also, this alteration of the osteo/adipogenic processes is observed 
in other bone loss conditions, such as aging, immobilization, 
microgravity, ovariectomy, diabetes, and glucocorticoid or thia-
zolidinedione treatments, highlighting the harmful consequence 
of marrow adipogenesis in osteogenic disorders (37–39).
Osteoblasts and adipocytes originate from a common precur-
sor, MSCs; preserving bone tissue requires adequate osteoblastic 
differentiation while minimizing adipogenesis. Commitment 
and differentiation of MSCs into a specific phenotype in  vivo 
is postulated to be controlled by hormonal and local factors 
(paracrine/autocrine) regulating the expression and/or activity 
of master differentiation genes (32, 40). Research on MSCs dif-
ferentiation in  vitro showed that activation of PPARγ2 and C/
EBPs match to the master transcription factors for adipogenic 
differentiation (41–43), while Runx2 and osterix are required 
for osteogenic differentiation (44). PPARγ2 positively regulates 
adipocyte differentiation while acting as a dominant negative 
regulator of osteogenic differentiation (45, 46). By contrast, an 
increase in bone mass density was observed in PPARγ2-deficient 
mice model (47). On the other hand, Runx2 expression by MSCs 
inhibits their differentiation into adipocytes, as shown by experi-
ments in Runx2/calvarial cells, which spontaneously differentiate 
into adipocytes (48). However, due to the heterogeneity of the 
earliest MSC, cell expression of only adipogenic or osteogenic 
markers is unlikely. Indeed, osterix positive marrow adipo-
cytes have been shown in lineage tracing studies, and marrow 
adipocytes can be traced to peroxiredoxin 1 (Rosen, personal 
communication). Moreover, some Runx2-positive cells isolated 
in high marrow adiposity states also have large lipid droplets and 
express perilipin (49).
Thus, in most cases, there is a reciprocal relationship in the reg-
ulation of these differentiation processes whose alteration would 
facilitate adipose accretion in the bone marrow, at the expense of 
osteoblast formation, decreasing bone mass (50–52). Such altered 
conditions would prevail in the bone marrow of osteoporotic 
patients and other bone loss conditions, disrupting the activities 
of MSCs and their microenvironment (37, 40, 50). This proposi-
tion has been termed the obesity theory of osteoporosis.
According to this proposition, observations in iliac crest 
biopsies from elderly women show considerable accumula-
tion of adipocytes; i.e., 70–80% of the total marrow volume in 
osteoporotic patients, compared to that of healthy elderly women. 
More recently, observations done by magnetic resonance imag-
ing (MRI) allowed similar conclusion in patients with low bone 
density (53–55). However, the origin of marrow adipocytes and 
their true nature has been more difficult to discern.
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HUMan Bone MarroW Fat
In newborn mammals, there is scarce marrow fat; however, 
adipocyte number increases with age such that in humans older 
than 30 years, most of the femoral cavity is occupied by adipose 
tissue (56). The function of human marrow fat was largely 
overlooked; at first, it was considered “filler” for the void left by 
trabecular bone during aging or after radiation treatments. Early 
observations from the 1970s highlighted the different charac-
teristics between adipocytes within the red and yellow marrow, 
suggesting that marrow adipocytes may have a region-specific 
lipid composition (57, 58). In humans, adipocytes accumulate 
within the yellow marrow at or slightly before birth, regardless 
of prematurity, and accelerate between 4 and 8 weeks of age (59, 
60). Early adipose tissue is established in distal skeletal regions, 
including the hands, feet, and distal tibia. This is often called 
constitutive marrow fat. After attaining some bulk, distal mar-
row adipose tissue histologically resembles peripheral white 
adipose tissue, and is relatively devoid of active hematopoiesis. 
During adulthood, marrow fat accretion continues in areas of 
red, hematopoietic marrow (61), which show histologically 
single adipocytes interspersed with sites of active hematopoiesis. 
These regions appear to be spatially distinct in rats and mice; but 
in human, both types of adipose tissue may allocate in the same 
skeletal region (62).
In a recent study in mice, Scheller et al. (62) related region-
specific fat differences in development to functional differences, 
such as regulation, adipocyte size, lipid composition, gene expres-
sion, and genetic determinants of marrow adipocytes, proposing 
that distal fat areas embody constitutive marrow adipose tissue 
(cMAT), while proximal adipose tissue contains regulated mar-
row adipose tissue (rMAT). Although cMAT showed histologic 
similarities with white extra-medullar adipose tissue (WAT), the 
lipid composition, cold regulation, and gene expression of WAT 
is more related to that of rMAT, concluding that lipid metabolism 
in WAT and rMAT adipocytes may be similar. Of note, cMAT 
showed increased unsaturation index compared to both, rMAT 
and WAT. Scheller’s study and those of others highlight that not 
all marrow adipocytes are equivalent, sustaining connotation for 
the marrow niche and its relationship to skeletal and whole-body 
metabolism.
Bone marrow fat has a role in systemic and local energy 
metabolism (63–66). When dysfunctional, it may disrupt the 
complex relationships in the bone marrow microenvironment, 
constraining functioning of both HSCs and MSCs, and thereby 
affecting their progeny (67, 68).
Bone marrow adipocytes have endocrine, autocrine, and 
paracrine effects; the activity of these cells on neighboring 
marrow result from the production of adipokines, steroids, 
cytokines, and free fatty acids (51, 64, 69–71), which could 
sustain or suppress the hematopoietic and osteogenic processes 
(10, 50, 51, 63, 64, 72).
The modification of bone marrow adipose tissue, either in 
size or function, may have similar consequences to that of extra 
medullary fat, which by unbalanced production of signaling 
products underlay in several human diseases, including obesity, 
lipodystrophy, atherogenesis, diabetes, and inflammation.
MarroW Fat CoMposition and 
osteoporosis
Current information on bone marrow fat points to diverse adi-
pocytes that have development-dependent skeletal distribution, 
showing distinct properties, such as lipid composition, gene 
expression, and probably subjected to different peripheral and 
local regulation. Underlying the relationship between such bone 
marrow fat and bone function is a balance in the number and 
quality of adipose cells; hence, the interest in characterizing bone 
marrow fat and searching for the quality of human marrow fat, for 
instance, in a bone remodeling disorder like osteoporosis.
Skeletal and marrow cells utilize fatty acids as substrates 
for their energy needs (73), although the contribution of mar-
row adipocytes to such requirements is most unknown; as it is 
the role of fatty acids stored in the marrow adipocytes in bone 
remodeling and hematopoiesis. Moreover, the lipid composition 
in the interstitial compartment surrounding bone marrow cells, 
its physiological significance, its variation under a bone stress 
situation, or its relationship with systemic lipids are undefined.
Studies on the composition of bone marrow fat suggested that 
it could have clinical relevance, in addition to marrow fat size 
and volume. Such conclusion is derived from in situ non-invasive 
MRI-based analysis of bone marrow, in patients with chronic 
diseases, such as osteoporosis (54), type 2 diabetes mellitus (74), 
or diabetic and non-diabetic women with prevalent fragility 
fractures (75). These studies demonstrated significantly lower 
unsaturation of bone marrow lipids in patients than correspond-
ing controls. Moreover, Patsch and colleagues showed that low 
unsaturation and high saturation levels of lipids was accentuated 
in diabetic patients with prevalent fractures (75).
Physiological levels of molecules in the human bone mar-
row milieu are practically unknown; measurement has been 
particularly difficult not only because of tissue seclusion, but 
because of the complicated anatomy and blood perfusion of bone 
requiring invasive bone marrow sampling. Thus, knowledge on 
the availability to bone marrow cells of metabolites or regulatory 
compounds is scarce, limited to some pathologic condition or 
estimated from measurements in plasma (69, 76–78). A soluble 
fraction, named “bone marrow serum (BMS),” obtained after 
spinning human bone marrow aspirates allows measurement 
of physiologically significant concentrations in the bone cell 
microenvironment, which are dissimilar from circulating plasma 
or whole blood (70, 79, 80).
In such fraction, we tested the hypothesis that BMS reflects the 
uniqueness of the marrow compartment in respect to the seques-
tration and utilization of fatty acids, by studying the composition 
of total soluble fatty acids in BMS and plasma samples from con-
trol and osteoporotic women with and without hip fracture (81). 
Results revealed a specific pattern of fatty acid composition in the 
bone marrow milieu that was characterized by higher saturated 
and decreased unsaturated fatty acids, compared to that of the 
circulation. The proportion of fatty acids in the BMS varied in 
the range of lipids in plasma, but its relative levels of unsaturated 
and saturated fatty acids compares well to those observed in the 
human marrow fat tissue (62, 75, 82), implying a distinct lipid 
content in BMS that replicates relevant fatty acids derived from 
FiGUre 1 | relationship between hip fracture and fatty acid 
composition in the bone marrow serum of osteoporotic women.
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the activity of adipocytes and other marrow cells, rather than 
those provided by blood plasma. The lipid content in BMS of 
all women studied suggests an active exchange of lipids between 
marrow cells; thus, the surplus of saturated fatty acids in BMS 
could result from palmitic and stearic acids supplied mainly by 
adipocytes, while marrow cells apparently preserve their pool of 
unsaturated fatty acids, except for oleic acid that is higher in BMS 
than in plasma (81).
By contrast, when the content of fatty acids in BMS and 
blood plasma was evaluated according to women’s bone mass 
density, no consistent differences in fatty acid composition were 
apparent in BMS, nor in plasma, which is analogous to former 
observations on the composition of bone fat tissue (53, 54, 74). 
Notwithstanding, there was a trend toward higher saturation and 
lower unsaturation in BMS fatty acids as compared to plasma. 
The analysis of the relative proportion of individual fatty acids 
suggests an active distribution of unsaturated fatty acids.
The former conclusion is supported by further analysis of 
data on the composition of fatty acids in both BMS and plasma 
in the osteoporosis group, in relation to the presence or not of 
a hip fracture (Figure  1). A switch toward decreased content 
of total saturated versus unsaturated fatty acids was observed 
in BMS of women with fractures, emphasizing a dynamic 
relationship between the composition of fatty acid in the bone 
microenvironment and the metabolic requirements of cells. 
In women with fractures, stearic acid content significantly 
decreased concomitant with increased oleic acid content, 
implying a substrate to product relationship to fulfill specific 
requirements for unsaturated fatty acids. Moreover, increased 
activity of cyclooxygenase (COX), COX-2 could be proposed 
from the total removal of polyunsaturated eicosatrienoic and 
arachidonic fatty acids (81).
It is difficult to define the origin (adipocyte or other marrow cell 
production) and type of lipids that change the fatty acid content of 
the BMS fraction after fracture, in part because the measurement 
was limited to the total fatty acid pool in the soluble fraction of 
the bone marrow. After a hip fracture bone cell metabolism may 
change in order to provide extra energy for damage repair by 
osteoblasts, or to suppress excessive inflammation. Interestingly, 
the lipid fraction in BMS of fractured women appears adjust to 
such conditions, thus diminished level of saturated fatty acid 
could result from increased supply of energetic substrate to 
marrow cells (bone, fat, and hematopoietic), while an increased 
exchange of oleic and polyunsaturated fatty acids could be related 
to their regulatory functions.
In conclusion, in this report, we summarize evidence on the 
role that adipocytes may play in the bone marrow in health and 
disease. Bone marrow adipose tissue appears as distinct from 
other extra marrow fat tissues, heterogeneous in its development, 
and allocated in subpopulations that seem to have different physi-
ological properties. The regulation of the number and quality 
adipocytes is a necessity to preserve a functional bone marrow 
microenvironment to sustain SCs. In a bone disease like osteo-
porosis, there is increased differentiation of the precursor MSCs 
toward adipocytes, altering the local marrow microenvironment 
but leading to bone loss. In addition to fat mass, the quality of 
lipids could also participate in disrupting local regulation; hence, 
the interest in knowing the fatty acid composition of marrow 
adipose tissue. The measurement of the fat composition in 
BMS portrays a dynamic exchange of fatty acids in this fraction 
implying the connotation of locally produced lipids. The fatty 
acid composition in the BMS is enriched in saturated fatty acids 
and decreased in unsaturated fatty acids, as compared to blood 
plasma. Therefore, it is clear that qualitative aspects of marrow 
adiposity provide significant insights into the metabolism of the 
bone marrow niche, and may offer clues as to the pathophysiology 
of bone diseases, such as osteoporosis.
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